Agostino Tafuri

Pubblicazioni

Titolo Pubblicato in Anno
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: report from the Multiple Myeloma Gimema Lazio Group EUROPEAN JOURNAL OF HAEMATOLOGY 2022
A prognostic model for patients with lymphoma and COVID-19. a multicentre cohort study BLOOD ADVANCES 2022
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma. A Fondazione Italiana Linfomi real-life experience HEMATOLOGICAL ONCOLOGY 2022
COVID-19 infection in chronic myeloid leukaemia after oneyear of the pandemic in Italy. A Campus CML report BRITISH JOURNAL OF HAEMATOLOGY 2022
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma JOURNAL OF CLINICAL MEDICINE 2022
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group LEUKEMIA & LYMPHOMA 2022
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study FRONTIERS IN ONCOLOGY 2022
Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform FRONTIERS IN ONCOLOGY 2022
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group ANNALS OF HEMATOLOGY 2022
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide BLOOD CANCER JOURNAL 2022
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity? JOURNAL OF CLINICAL MEDICINE 2022
[18F]FDG PET/CT in Patients Affected by SARS-CoV-2 and Lymphoproliferative Disorders and Treated with Tocilizumab JOURNAL OF PERSONALIZED MEDICINE 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience FRONTIERS IN ONCOLOGY 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study THE LANCET. HEALTHY LONGEVITY 2022
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV HEMATOLOGICAL ONCOLOGY 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study THE LANCET. HEALTHY LONGEVITY 2022
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study EUROPEAN JOURNAL OF HAEMATOLOGY 2022
How to improve educational behaviors for caregivers and patients having Central Venous Access Device (CVAD). a scoping review WORLD CANCER RESEARCH JOURNAL 2021
Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies JOURNAL OF TRANSLATIONAL MEDICINE 2021

ERC

  • LS1_9
  • LS2_15
  • LS3_1
  • LS3_5
  • LS4_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Studio dei meccanismi di resistenza della cellula leucemica ed identificazione del ruolo patogenetico e prognostico di profili aberranti proteomici e metabolomici implicati nei meccanismi proliferativi ed apoptotici. Sviluppo preclinico di molecole sperimentali con potenziale ruolo terapeutico target-specifico nelle onco-emopatie. Studio dei profili proteomici e metabolomici in cellule staminali  emopoietiche umane normali e nella controparte leucemica. 

Keywords

Acute leukemia
molecular targeted therapies
drug resistance
cell signaling
cell metabolism

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma